Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Andy Rawstron, PhD, Claudia Fazi, PhD, Neus Villamor, MD PhD, Julio Delgado, MD PhD, Remi Letestu, MD PhD, Florence Cymbalista, MD, Carlos Palacio, Francesc Bosch, MD PhD, Ruth M De Tute, MSc, Stuart Liptrot, David O'Brien, FAMLs, Martin Spacek, MD, PhD, Johan Dobber, Arnon P. Kater, MD PhD, Peter C Gambell, David A Westerman, MBBS, FRACP, FRCPA, Asha Soosapilla, Stephen P. Mulligan, MBBS, PhD FRACP, FRCPA, Gerard Lozanski, MD, Ke Lin, PhD, Andrew R Pettitt, MRCP, PhD, Gabi Brachtl, Alexander Egle, MD, David W Williamson, PhD, Catherine M Sanders, PhD, Harlan Robins, PhD, Justin Boysen, Tait D. Shanafelt, MD, Curtis A. Hanson, MD, Jeffrey L. Jorgensen, MD PhD, William G. Wierda, MD PhD, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Laura Rassenti, PhD, H. Elizabeth Broome, MD, Thomas J. Kipps, MD PhD, Mathieu Hauwel, Iuri Marinov, Fiona E. Craig, MBBS, Nomdedeu Josep, Carol Moreno, MD, Olga Stehlikova, MSc., Michael Doubek, Sarka Pospisilova, Prof., Dr., PhD, Karl-Anton Kreuzer, MD, Michael Hallek, MD, Peter Hillmen, MBChB, PhD, Emili Montserrat, MD PhD, Paolo Ghia, MD

Blood (2014) 124 (21): 1976.

https://doi.org/10.1182/blood.V124.21.1976.1976

Published: 2014

Journal Articles

Clinical Monoclonal B Lymphocytosis (cMBL), Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): Diagnostic Criteria, Features At Diagnosis and Natural History

Rodrigo Santacruz, MD, Julio Delgado, MD, PhD, Tycho Baumann, MD, Maria Rozman, MD, Martha Aymerich, MD, Magda Pinyol, Arturo Pereira, MD, PhD, Cristina Royo, Alba Navarro, Cristina Lopez, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 5273.

https://doi.org/10.1182/blood.V122.21.5273.5273

Published: 2013

Journal Articles

A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study

Blood (2013) 122 (21): 1645.

https://doi.org/10.1182/blood.V122.21.1645.1645

Published: 2013

Journal Articles

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Tycho Baumann, MD, Julio Delgado, MD, PhD, Rodrigo Santacruz, MD, Alejandra Martínez-Trillos, MD, Cristina Royo, PhD, Alba Navarro, PhD, Magdalena Pinyol, PhD, María Rozman, MD, PhD, Cristina López, PhD, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Arturo Pereira, MD, PhD, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 4155.

https://doi.org/10.1182/blood.V122.21.4155.4155

Published: 2013

Journal Articles

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Pau Abrisqueta, MD, Neus Villamor, MD, PhD, María José Terol, MD, PhD, Eva González-Barca, MD, PhD, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose Antonio García-Marco, MD, PhD, Yolanda González, MD, Felix Carbonell, MD, PhD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, MD, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD, Francesc Bosch, MD, PhD

Blood (2012) 120 (21): 3930.

https://doi.org/10.1182/blood.V120.21.3930.3930

Published: 2012

Journal Articles

Global Methylation Provides Independent Prognostic Information in Chronic Lymphocytic Leukemia and Is Associated with a Microrna Signature

Alfons Navarro, PhD, Gerardo Ferrer, PhD, Marina Díaz-Beyá, MD, Carmen Muñoz, PhD, Rut Tejero, Tania Díaz, PhD, Mariano Monzó, MD, PhD, Emili Montserrat, MD. PhD

Blood (2012) 120 (21): 3873.

https://doi.org/10.1182/blood.V120.21.3873.3873

Published: 2012

Journal Articles

Expression Profile and Regulation of BAFF and APRIL Receptors in Chronic Lymphocytic Leukemia,

Gerardo Ferrer, Msc, Kate E Hodgson, MBBS, MRCP, FRCPath, Victor Ciria, Tycho Baumann, MD, Gael Roue, Dolors Colomer, MD. PhD, Emili Montserrat, MD. PhD, Carol Moreno, MD, PhD

Blood (2011) 118 (21): 3880.

https://doi.org/10.1182/blood.V118.21.3880.3880

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Gerardo Ferrer, Msc, Alfons Navarro, PhD, Kate E Hodgson, MBBS, MRCP, FRCPath, Dolors Colomer, MD. PhD, Marta Aymerich, MD. PhD, Tycho Baumann, MD, Arturo Pereira, MD. PhD, Mariano Monzó, MD, PhD, Carol Moreno, MD, PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3897.

https://doi.org/10.1182/blood.V118.21.3897.3897

Published: 2011

Journal Articles

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Gabriela Ghita, MD, Julio Delgado, MD. PhD, Tycho Baumann, MD, Ivan Dlouhy, MD, Marta Aymerich, MD. PhD, Dolors Colomer, MD. PhD, María Rozman, Neus Villamor, MD. PhD, Natalia Creus, MD. PhD, Arturo Pereira, MD. PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3908.

https://doi.org/10.1182/blood.V118.21.3908.3908

Published: 2011

Journal Articles

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)

Francesc Bosch, MD, PhD, Pau Abrisqueta, Neus Villamor, MD. PhD, María José Terol, MD, PhD, Eva González-Barca, MD, Marcos González, MD, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A. Garcia-Marco, MD, PhD, Yolanda Gonzalez, Felix Carbonell, MD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, Ana Muntanola, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 293.

https://doi.org/10.1182/blood.V118.21.293.293

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Apoptotic Cell Death Induced by Glucocorticoids Is Mediated by BIM and GILZ and Can Be Predicted by FKBP5 Basal Expression Levels.

Maria Joao Baptista, MSc, Ana Muntañola, MD, Carles Codony, PhD, Eva Calpe, Eva Fernandez, Marta Crespo, PhD, Pau Abrisqueta, MD, Eva Gine, MD, Susana G Kalko, PhD, Pedro Jares, PhD, Emili Montserrat, MD, PhD, Francesc Bosch, MD, PhD

Blood (2009) 114 (22): 1236.

https://doi.org/10.1182/blood.V114.22.1236.1236

Published: 2009

Journal Articles

Conventional and Molecular Cytogenetic Responses in Patients with Myelodysplastic Syndrome (MDS) with Deletion 5q Treated with Lenalidomide.

Rita Coutinho, MD, Dolors Costa, PhD, Ana Carrió, PhD, Ana Vidal, BS, Mohammed Belkaid, MS, Elias Campo, MD, PhD, Emili Montserrat, MD, PhD, Benet Nomdedeu, MD

Blood (2009) 114 (22): 1746.

https://doi.org/10.1182/blood.V114.22.1746.1746

Published: 2009

Journal Articles

Formin-Like Gene Expression in Chronic Lymphocytic Leukemia Is Associated with Unfavorable Prognostic Factors and Clinical Outcome

Eva Calpe, PhD, Antonio Martinez, MD, PhD, Patricia Favaro, PhD, Marta Crespo, PhD, Carles Codony, PhD, Ma.ÂJoao Gomes Baptista, MSc, PharmD, Eva Gine, Emili Montserrat, MD, PhD, Francesc Bosch, MD, PhD

Blood (2008) 112 (11): 4181.

https://doi.org/10.1182/blood.V112.11.4181.4181

Published: 2008

Journal Articles

Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma

Alfons Navarro, PhD, Tania Diaz, Antonio Martinez, MD, PhD, Anna Gaya, MD, Aina Pons, Carmen Martinez, MD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD

Blood (2008) 112 (11): 518.

https://doi.org/10.1182/blood.V112.11.518.518

Published: 2008

Journal Articles

Changes in the Natural History, Treatment Modalities, and Survival Patterns in Patients with Chronic Lymphocytic Leukemia (CLL) from 1980 to 2008. The Hospital Clinic of Barcelona Experience

Pau Abrisqueta, MD, Francesc Bosch, MD, PhD, Marta Aymerich, MD, PhD, Eva Gine, MD, Carol Moreno, MD, PhD, Maria Rozman, MD, PhD, Neus Villamor, MD, PhD, Elias Campo, MD, PhD, Ciril Rozman, MD, PhD, Emili Montserrat, MD, PhD

Blood (2008) 112 (11): 48.

https://doi.org/10.1182/blood.V112.11.48.48

Published: 2008

Journal Articles

BCL-2 Phosphorylation Modulates Sensitivity to the BH3-Mimetic GX15-070 (Obatoclax) and Reduces Its Synergistic Interaction with Bortezomib in Chronic Lymphocytic Leukemia Cells.

Patricia Perez Galan, PhD, Gael Roue, PhD, Monica Lopez Guerra, BS, Neus Villamor, MD, PhD, Emili Montserrat, MD, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD

Blood (2007) 110 (11): 3464.

https://doi.org/10.1182/blood.V110.11.3464.3464

Published: 2007

Journal Articles

Preliminary Results of the Combination Rituximab, Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) Followed by Rituximab Maintenance in Previously Untreated Chronic Lymphocytic Leukemia (CLL).

Francesc Bosch, MD, PhD, Ana Muntañola, MD, Neus Villamor, MD, Maria Jose Terol, MD, Elena Gonzalez-Barca, MD, Josep Maria Ribera, MD, PhD, Marcos Gonzalez, MD, Eugenia Abella, MD, Julio Delgado, MD, Felix Carbonell, MD, PhD, Jose A. Garcia-Marco, MD, PhD, Lourdes Escoda, MD, Secundino Ferrer, MD, E. Monzo, MD, Yolanda Gonzalez, MD, Pau Abrisqueta, MD, Olga Salamero, MD, Eva Gine, MD, Emili Montserrat, MD, PhD

Blood (2007) 110 (11): 626.

https://doi.org/10.1182/blood.V110.11.626.626

Published: 2007

Journal Articles

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Alfons Navarro, PhD, Anna Gaya, MD, Aina Pons, PhD, Pau Abrisqueta, MD, Bernat Gel, PhD, Antonio Martinez, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Carmen Martinez, MD, PhD, Miquel Granell, MD, Rosa Artells, PhD, Sonia Jansa, PhD, Alvaro Urbano-Ispizua, MD, PhD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD

Blood (2006) 108 (11): 474.

https://doi.org/10.1182/blood.V108.11.474.474

Published: 2006

Journal Articles

FMNL-1 (Formin-Like 1) Gene in Chronic Lymphocytic Leukemia (CLL) Is Overexpressed in Young Patients with Adverse Prognostic Factors and Poor Outcome.

Eva Calpe, PhD, Patricia M.B. Favaro, PhD, Marta Crespo, PhD, Maria Joao Baptista, PhD, Ana Muntañola, MD, Eva Giné, MD, Sara Saad, MD, Emili Montserrat, MD, PhD, Francesc Bosch, MD

Blood (2006) 108 (11): 2775.

https://doi.org/10.1182/blood.V108.11.2775.2775

Published: 2006

Journal Articles

Equilibrative Nucleoside Transporter-2 (ENT2) Protein Correlates with Ex-Vivo Sensitivity to Fludarabine in Chronic Lymphocytic Leukemia (CLL)-Cells.

Silvia Marce, Miriam Molina-Arcas, Neus Villamor, MD, PhD, Isabel Huber, F. Javier Casado, PhD, Beatriz Bellosillo, PhD, Emili Montserrat, MD, PhD, Marcal Pastor-Anglada, PhD, Dolors Colomer, PhD

Blood (2004) 104 (11): 2079.

https://doi.org/10.1182/blood.V104.11.2079.2079

Published: 2004

NARROW

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Clinical Monoclonal B Lymphocytosis (cMBL), Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): Diagnostic Criteria, Features At Diagnosis and Natural History

A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Global Methylation Provides Independent Prognostic Information in Chronic Lymphocytic Leukemia and Is Associated with a Microrna Signature

Expression Profile and Regulation of BAFF and APRIL Receptors in Chronic Lymphocytic Leukemia,

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)

Chronic Lymphocytic Leukemia Apoptotic Cell Death Induced by Glucocorticoids Is Mediated by BIM and GILZ and Can Be Predicted by FKBP5 Basal Expression Levels.

Conventional and Molecular Cytogenetic Responses in Patients with Myelodysplastic Syndrome (MDS) with Deletion 5q Treated with Lenalidomide.

Formin-Like Gene Expression in Chronic Lymphocytic Leukemia Is Associated with Unfavorable Prognostic Factors and Clinical Outcome

Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma

Changes in the Natural History, Treatment Modalities, and Survival Patterns in Patients with Chronic Lymphocytic Leukemia (CLL) from 1980 to 2008. The Hospital Clinic of Barcelona Experience

BCL-2 Phosphorylation Modulates Sensitivity to the BH3-Mimetic GX15-070 (Obatoclax) and Reduces Its Synergistic Interaction with Bortezomib in Chronic Lymphocytic Leukemia Cells.

Preliminary Results of the Combination Rituximab, Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) Followed by Rituximab Maintenance in Previously Untreated Chronic Lymphocytic Leukemia (CLL).

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

FMNL-1 (Formin-Like 1) Gene in Chronic Lymphocytic Leukemia (CLL) Is Overexpressed in Young Patients with Adverse Prognostic Factors and Poor Outcome.

Equilibrative Nucleoside Transporter-2 (ENT2) Protein Correlates with Ex-Vivo Sensitivity to Fludarabine in Chronic Lymphocytic Leukemia (CLL)-Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only